-
Nordic Pharma files submission to health Canada for the marketing authorization of methotrexate autoinjector for treating rheumatoid arthritis in Canada
-Canada, March 29, 2022 – NORDIC PHARMA, a SEVER Life Sciences company, announced today the submission of a New Drug…
0 -
Nordic Pharma has acquired ALTIM® (cortivazol) pre-filled syringe to strengthen their Rheumatology portfolio
-Paris, January 2022 – Nordic Pharma is pleased to announce that they have entered into an agreement with SANOFI to…
-
European Commission approves Teysuno in metastatic colorectal cancer
-Nordic Pharma announces that on the 24th of January, the European Commission (EC) approved the new indication for Teysuno® (tegafur/gimeracil/oteracil)…
-
Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer
-Nordic Pharma has announced that on 16 December 2021, the Committee for Medicinal Products for Human Use (CHMP) adopted a…
-
Nordic Pharma present at CPhI !
-Nordic Pharma will be attending CPhI Worldwide in Milan, Italy from November 9th-11th 2021. We are actively looking for late stage partnering…
-
Nordixate® Methotrexate Pre-filled Syringe approved in Colombia
-Nordic Pharma AAP is pleased to announce that the Nordixate® Methotrexate Pre-filled Syringe has been issued market authorization by Instituto…
-
New Headquarters Offices
-Both of Nordic Pharma HQs, located in France and in the Netherlands, have recently moved. Nordic Pharma HQ NL has…
-
Nordimet® PFS and Pen are launched in Chile!
-Nordic Pharma Americas, Asia, Pacific are pleased to announce that as of the 15th of April, Nordimet® PFS and Pen are…
Author archive for admin
Nordic Pharma > Articles by: admin